THE AMERICAS AFRICA ASIA

| HOME | TABLE OF CONTENTS | ACKNOWLEDGEMENTS | ACRONYMS AND ABBREVIATIONS | USERS’ GUIDE AND EXPLANATORY NOTES | FOREWORD | INTRODUCTION | I: GLOBAL MALARIA SITUATION | II: MALARIA CONTROL, BY REGION | III: GLOBAL FINANCING | IV: IMPROVING RBM MONITORING AND EVALUATION | REFERENCES |
RBM PartnershipUNICEFWHO/RBM Department

ANNEX 2.

COUNTRY DATA, BY REGION

List of regional tables

Table A.1 Summary of key strategies and policies of national malaria control programmes
Table A.2 Antimalarial drug policy, end 2004
Table A.3 Summary of finances available for malaria control (in US$ thousands)
Table A.4 Summary of committed and disbursed malaria funds available from the Global Fund to Fight AIDS, Tuberculosis and Malaria (in US$)
Table A.5 Summary of malaria-related service delivery
Table A.6 Summary of antimalarial drug efficacy results expressed as treatment failure
Table A.7 Percentage of households that have at least one mosquito net, by background characteristics
Table A.8 Percentage of households that have at least one insecticide-treated net, by background characteristics
Table A.9 Percentage of children under 5 years of age that slept under a mosquito net during the night preceding the survey, by background characteristics
Table A.10 Percentage of children under 5 years of age that slept under an insecticide-treated net during the night preceding the survey, by background characteristics
Table A.11 Percentage of pregnant women that slept under a mosquito net during the night preceding the survey, by background characteristics
Table A.12 Percentage of pregnant women that slept under an insecticide-treated net during the night preceding the survey, by background characteristics
Table A.13 Percentage of children under 5 years of age with reported fever in the two weeks prior to the survey, by background characteristics
Table A.14 Percentage of febrile children under 5 years of age who received treatment with CQ, by background characteristics
Table A.15 Percentage of febrile children under 5 years or age who received treatment with SP, by background characteristics
Table A.16 Percentage of febrile children under 5 years of age who received treatment with any antimalarial, by background characteristics
Table A.17 Pregnant women receiving SP at least once during pregnancy (community level, prevention or treatment), by background characteristics
Table A.18 Pregnant women receiving SP at least twice during pregnancy (community level, prevention or treatment), by background characteristics
Table A.19 Pregnant women receiving SP at least once during an antenatal visit, by background characteristics
Table A.20 Pregnant women receiving SP at least twice during an antenatal visit, by background characteristics
Table A.21 Reported malaria for the most recent year information received
Table A.22 Standardized reported malaria cases and rates per 1000 since 1990